Close Menu

BGI

The partners plan to apply genomics to traditional Chinese medicine.

The researchers said that better diagnostics are needed to distinguish between false preterm labor and true preterm labor to prevent unnecessary treatment.

The partners are initially planning to make searchable whole-genome data and EMRs from more than 1,000 rheumatoid arthritis patients accessible to trial developers.

The partners will use Hummingbird's miRNA database and expertise in sample preparation as well as BGI's BGISEQ sequencer and analysis pipeline to develop targeted miRNA IVD assays.

The funding is being provided by Genome Canada, as well as various Canadian provinces, businesses, and research institutes.

BGI is also developing sequencing-based self-sampling assays for pharmacogenomics and hereditary cancer testing.

The company recently released the MGISEQ-2000, MGISEQ-200, and MGIFLP sequencing platforms, as well as the MGIUS-R3 robotic ultrasound system.

The new agreement between the two companies commits to expanding the clinical genetic testing market in Turkey and is part of a global expansion for BGI.

The new institute, co-located with the China National GeneBank, will focus on synthetic biology technologies and applications. 

Researchers found microbial communities at sites of the female reproductive tract thought to be sterile, and linked certain microbes to disease states.

Pages

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.